Prevention of renal function loss after non-renal solid organ transplantation - How can nephrologists help to keep the kidneys out of the line of fire?

Nephrology Dialysis Transplantation

Volumn 14, Issue 8, 1999, Pages 1841-1843

  Broekroelofs, Jan ^b   Stegeman, Coen A ^a   Navis, Gerjan ^b   De Jong, Paul E ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RECIPIENT;

HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; NEPHROLOGY; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD;

EID: 0032803733     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.8.1841     Document Type: Editorial

References (13)

1. Paul LC. Chronic renal transplant loss. Kidney Int 1995; 47: 1491-1499
2. Pattison JM, Petersen J, Kuo P, Valantine V, Robbins C, Theodore J. The incidence of renal failure in one hundred consecutive heart-lung transplant recipients. Am J Kidney Dis 1995; 26: 643-648
3. Klompmaker IJ, Homan van der Heide JJ, Tegzess AM et al. Effects of cyclosporin A withdrawal on renal function and renal stimulation in liver transplant patients treated with triple drug immunosuppression for over two years. Nephrol Dial Transplant 1994; 9: 1629-1633
4. Navis GJ, Broekroelofs J, Mannes GPM, Bij van der W, Tegzess AM, de Jong PE. Renal hemodynamics after lung transplantation: a prospective study. Transplantation 1996; 61: 1600-1605
5. Myers BD, Ross J, Newton L, Luetscher J, Perloth M. Cyclosporin-associated chronic nephropathy. N Engl J Med 1984; 311: 699-705
6. Abrass CK, Berfield AK, Stehman-Breen C, Alpers CE, Davis CL. Unique changes in interstitial extracellular matrix composition are associated with rejection and cyclosporine toxicity in human renal allograft biopsies. Am J Kidney Dis 1999; 33: 11-20
7. Opelz G, Wujciak T, Ritz E. Association of chronic kidney graft failure with recipient blood pressure. Kidney Int 1998; 53: 217-222
8. Spencer CM, Goa KL, Gillis JC. Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs 1997; 54: 925-975
9. Broekroelofs J, Navis G, Stegeman CA, van der Bij W, de Jong PE. Lung transplantation [letter]. Lancet 1998; 351: 1064
10. Chan C, Maurer J, Cardella C, Cattran D, Pei Y. A randomized controlled trial of verapamil on cyclosporine nephrotoxicity in heart and lung transplant recipients. Transplantation 1997; 63: 1435-1440
11. Broekroelofs J, de Haan J, Stegeman CA, Navis GJ, de Zeeuw D, de Jong PE. Validity of slopes calculated from reciprocal serum creatinine (1000/Cr) or Cockcroft clearance (ClCockr) in detecting rate of renal function loss after lung transplantation [abstract]. J Am Soc Nephrol 1998; 9: 68
12. Myers BD, Sibley R, Newton L, Tomlanovich SJ et al. The long-term of cyclosporin-associated chronic nephropathy. Kidney Int 1988; 33: 590-600
13. Isoniemi H, Taskinen E, Hayry P. Histological chronic allograft damage index accurately predicts chronic renal allograft rejection. Transplantation 1994; 58: 1195-1198